about
Traditional medicines and globalization: current and future perspectives in ethnopharmacologyNeural correlates of the psychedelic state as determined by fMRI studies with psilocybinLysergic acid diethylamide: a drug of 'use'?Psychedelics"Research chemicals": tryptamine and phenethylamine use among high-risk youth.The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: an open, non-randomized case series.Alternative headache treatments: nutraceuticals, behavioral and physical treatments.Cannabinoids and hallucinogens for headache.Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists.Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD)Clinical applications of hallucinogens: A review.Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD).Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers.Molecular pharmacology and ligand docking studies reveal a single amino acid difference between mouse and human serotonin 5-HT2A receptors that impacts behavioral translation of novel 4-phenyl-2-dimethylaminotetralin ligandsThe good, the bad and the tasty: The many roles of mushrooms.Serotonergic agents in the management of cluster headache.Herbal treatment of headache.Hallucinogens and cannabinoids for headache.Hemicrania continua: functional imaging and clinical features with diagnostic implications.Cluster headache: potential options for medically refractory patients (when all else fails).Licit and illicit drug use in cluster headache.Acupuncture in cluster headache: four cases and review of the literature.Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?Potential Therapeutic Effects of Psilocybin.Mind-altering drugs and research: from presumptive prejudice to a Neuroscientific Enlightenment?: Science & Society series on "Drugs and Science"Psychedelics in the treatment of unipolar mood disorders: a systematic review.Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance.Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways.Analytical characterization of N,N-diallyltryptamine (DALT) and 16 ring-substituted derivatives.Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey.Signal transduction and modulating pathways in tryptamine-evoked vasopressor responses of the rat isolated perfused mesenteric bed.Psychedelic and nonpsychedelic LSD and psilocybin for cluster headache.Availability of websites offering to sell psilocybin spores and psilocybin.A case of cluster headache treated with rotigotine: clinical and neurophysiological correlates.Reply to: 'illicit drugs and cluster headache: an inevitable discussion'.Crystal Structure of an LSD-Bound Human Serotonin Receptor.Illicit drug use in cluster headache patients and in the general population: a comparative cross-sectional survey.LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: a qualitative study of acute and sustained subjective effects.Research on psychedelic substances.Effects of Schedule I drug laws on neuroscience research and treatment innovation.
P2860
Q21129278-0DB4A509-6068-4E24-9B4B-3DFB5AA41472Q24633222-9143C14E-2036-42C8-940C-9C87512E6D9AQ26746133-EB99189B-8652-47E7-BA53-495F27024ACEQ30359998-89251F39-9CD2-4DCB-B23B-E45E2CA7F797Q30368441-E059639B-4E5A-40CE-94A8-DFD40FC39BF9Q34131481-8ACC447A-C121-4849-8F57-5BF98DF85A82Q34166923-88BBEF28-8C9A-431E-B213-26094B6EB8C3Q34320242-D53CFD92-C14C-4938-B46F-FE71FE013353Q34396223-38891CFF-413B-4AF4-BB98-606E8E7D7FC9Q34497649-93B2BBF7-E532-4396-9698-D8563267AAB9Q34535259-BA4F2ECC-9F78-435E-857C-AA338D630162Q35737157-3C8D9580-45FF-47A9-B52A-2D0BCD476B6FQ35936959-870190F6-3893-42F5-9AE6-4BDE090D7116Q37331831-4D17E6D4-E2D5-4B67-A981-8578D951C1F3Q37570744-6557B8FA-E28F-47C0-BC6A-669EE832ECB7Q37832687-AC66EA14-F7E8-4611-AB42-4BF7C778DC52Q38048898-EF09720E-CE9D-477B-A8AD-1A6103280F02Q38048900-633F667E-FA2B-4784-9C48-D77AB6B27C5AQ38097848-EBAB7896-514A-4A16-A6E4-53A0853D9A1AQ38117644-835B3CA5-3C43-4A05-A5A3-6B4C48049D6CQ38203237-EF03350C-9CBD-4F4A-A6A7-01B412984A8EQ38215474-CC36E61F-720F-49E8-84D8-DDD420E298FCQ38351502-C8AB5501-6D5A-472F-B096-40057D2AB5E7Q38741517-0C8F20BB-079E-448E-B367-BA17E5C68BF1Q38798504-DE915006-E570-4E7A-A46D-0E19F48897CBQ39011321-BC9D59C1-FC5F-4552-9E1C-CF5A10327039Q39079288-999186E1-85CB-4961-8D77-9E83975A1E17Q39414464-896B337B-51B6-4149-AD5D-CA304C5E909AQ39834312-5E13A7AA-E5DE-4F89-94F6-21972043DA9DQ40288155-AC23B57A-3F0E-4E76-B5FC-A252E8FFD9CEQ41857128-9F482301-5ACD-41D9-8F93-9DCC684E5311Q42572559-F0DA8815-3F33-42D8-A524-F9CD39504D57Q43226439-B03E9D2E-B6AB-4CA4-88AC-2BEC2DCE0A3BQ45340718-BEB76B4E-6AFF-4998-AE5F-A05A79ACC6C5Q45799970-C24EA940-9555-44C0-9FBD-492ED9676C38Q46266293-C0DC62EC-C266-4461-A6B3-D31B669180C7Q46560533-D74FEFE7-F09C-44BD-8675-34B1D031B4B7Q47789825-E0116C15-FFAB-4097-AB4A-ABC60FC6E3D8Q48420021-59054C48-D566-489B-8C9B-F26963A1618AQ48463442-8F8A4B84-E0A2-4567-A023-7B3FF19E5E65
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Response of cluster headache to psilocybin and LSD.
@ast
Response of cluster headache to psilocybin and LSD.
@en
type
label
Response of cluster headache to psilocybin and LSD.
@ast
Response of cluster headache to psilocybin and LSD.
@en
prefLabel
Response of cluster headache to psilocybin and LSD.
@ast
Response of cluster headache to psilocybin and LSD.
@en
P2093
P1433
P1476
Response of cluster headache to psilocybin and LSD.
@en
P2093
Harrison G Pope
John H Halpern
R Andrew Sewell
P304
P356
10.1212/01.WNL.0000219761.05466.43
P407
P577
2006-06-01T00:00:00Z